Compare
GE HealthCare Technologies Inc. vs 3M Co vs Baxter International Inc vs Solventum Corp
| Latest fiscal year | GE HealthCare Technologies Inc. GEHC | 3M Co MMM | Baxter International Inc BAX | Solventum Corp SOLV |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $20.62B | $24.95B | $11.24B | $8.32B |
| Revenue growth (YoY) | +4.8% | +1.5% | +5.7% | +0.9% |
| Gross margin | 40.0% | 39.9% (computed) | 30.1% | 53.5% |
| Operating margin | 13.4% | 18.6% | -2.7% | 26.2% |
| Net margin | 10.1% | 13.0% | -8.5% | 18.7% |
| Net income | $2.08B | $3.25B | -$957.00M | $1.56B |
| EPS (Diluted) | $4.55 | $6.00 | -$1.87 | $8.88 |
| Operating cash flow | $1.99B | $2.31B | $845.00M | $369.00M |
| Free cash flow | $1.50B | $1.40B | $332.00M | -$10.00M |
| Cash & equivalents | $4.49B | n/a | $1.97B | $878.00M |
| Total assets | $36.91B | $37.73B | $20.05B | $14.29B |
| Total liabilities | $26.31B | $32.99B | $13.95B | $9.24B |
| Shareholders' equity | $10.39B | $4.75B | $6.10B | $5.05B |
| Return on year-end equity | 20.1% | 68.5% | -15.7% | 30.8% |
| Shares outstanding | n/a | 530.28M | n/a | 173.49M |
Revenue, most recent five fiscal years
| Fiscal year | GE HealthCare Technologies Inc. | 3M Co | Baxter International Inc | Solventum Corp |
|---|---|---|---|---|
| Latest | $20.62B Ended 2025-12-31 | $24.95B Ended 2025-12-31 | $11.24B Ended 2025-12-31 | $8.32B Ended 2025-12-31 |
| 1 year earlier | $19.67B Ended 2024-12-31 | $24.57B Ended 2024-12-31 | $10.64B Ended 2024-12-31 | $8.25B Ended 2024-12-31 |
| 2 years earlier | $19.55B Ended 2023-12-31 | $24.61B Ended 2023-12-31 | $10.36B Ended 2023-12-31 | $8.20B Ended 2023-12-31 |
| 3 years earlier | $18.34B Ended 2022-12-31 | $26.16B Ended 2022-12-31 | $10.06B Ended 2022-12-31 | $8.13B Ended 2022-12-31 |
| 4 years earlier | $17.59B Ended 2021-12-31 | $35.35B Ended 2021-12-31 | $12.15B Ended 2021-12-31 | n/a |